3211 Aggressive immunotherapy assists in functional recovery of NMOSD longitudinal myelitis, despite delayed treatment and advanced age

• Michal Lubomski,
• Francis Potter

Affiliations

Michal Lubomski

2Department of Neurogenetics, Kolling Institute, University of Sydney and Royal North Shore Hospital, Sydney, NSW, Australia

Francis Potter

Neurology, Royal North Shore Hospital, Sydney, NSW, Australia